SCR-LIP-000609 · Claim · JSON legível por máquina →
A hipermobilidade articular é frequentemente relatada entre mulheres com lipedema.
Proposição geral consolidada a partir de 4 claims anteriores de artigo único; o resultado de cada estudo aparece como achado.
Claim em resumo
- Tipo
- associação clínica
- Estado do conhecimento
- Emergente
- Certeza da evidência
- baixa (GRADE)
- Evidência
- 4 fonte(s)
- Responde a
- 1 pergunta(s)
- Datas
- 2026-11-20 → 2026-11-20
Evidência estruturada, compilada por máquina — não é um veredito.
Evidência ao longo do tempo
Evidência (4)
- Chondromalacia in Lipedema: The Sarcopenic–Valgus Cascade That Keeps Getting Missed — Amato (2025) ✓ verificado — consistente · review · 2025 · confiança da leitura: moderate
“Hipermobilidade articular generalizada (HAG) presente em ≥50% das mulheres com lipedema”
Review states generalized joint hypermobility is present in at least 50% of women with lipedema, possibly increasing joint loading and knee pain.
The article provides a framework that connects lipedema with joint hypermobility, indicating a potential increase in joint loading. - Lipedema: friend and foe — Torre et al. (2018) ✓ verificado — consistente · review · 2018 · confiança da leitura: moderate
“hipermobilidade em >50% (160 pacientes outro estudo)”
Review citing a prior study of 160 lipedema patients reports joint hypermobility in over 50%, noted as a risk factor for joint disease and aortic stiffness.
The narrative review reports a >50% prevalence of joint hypermobility among lipedema patients (citing prior data) and links hypermobility to lipedema, but provides no comparison group or adjusted analysis, so it offers only crude supportive - Standard of care for lipedema in the United States — Herbst et al. (2021) ✓ verificado — consistente · review · 2021 · confiança da leitura: high
“1.9 [A]: Comorbidades: hipermobilidade articular em 50% das mulheres (consistente com hEDS)”
US standard-of-care consensus guideline lists joint hypermobility in about 50% of women with lipedema as a comorbidity, consistent with hypermobile Ehlers-Danlos syndrome.
The guideline reports a 50% prevalence of joint hypermobility among women with lipedema as a comorbidity, but this is an unadjusted prevalence within a consensus guideline (Delphi/GRADE review) without a non-lipedema comparison group, so it [grade capped low->very_low per curated Oxford N6] - Intersection between hypermobile Ehlers-Danlos syndrome and adipose disorders: investigating fascial remodeling with ultrasound imaging — Wang et al. (2025) ✓ verificado — contextual · cohort · 2025 · confiança da leitura: high
“Tipos de lipedema (I 17,6%, II 23,5%, III 58,8%) e estágios (1: 23,5%, 2: 47,1%, 3: 29,4%, 4: 0%) compatíveis com dados epidemiológicos prévios em lipedema com hipermobilidade”
Ultrasound study of fascial remodeling included participants with both hypermobile Ehlers-Danlos syndrome and lipedema; lipedema types and stages matched prior data, without testing whether lipedema raises hypermobility prevalence.
The study includes participants with both hEDS and lipedema, providing insights into their relationship, but does not establish a direct causal link between lipedema and increased joint hypermobility.
Contexto (PECO)
Responde a estas perguntas
Lacunas e ressalvas
Histórico de mudanças
- 2026-11-20 — created_by_consolidation · general proposition consolidated from SQ-LIP-000005